GRAMANTIERI, LAURA
GRAMANTIERI, LAURA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Personale esterno ed autonomi
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
2022 Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D'errico A.; Piscaglia F.; Giovannini C.
Animal models of hepatocellular carcinoma prevention
2019 Shankaraiah R.C.; Gramantieri L.; Fornari F.; Sabbioni S.; Callegari E.; Negrini M.
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research
2022 Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study
2020 Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi F G; Tamburini E; Vivaldi C; Rizzato M D; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino G G; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu C; Scartozzi M
Brivanib in combination with Notch3 silencing shows potent activity in tumour models
2019 Giovannini C.; Salzano A.M.; Baglioni M.; Vitale M.; Scaloni A.; Zambrano N.; Giannone F.A.; Vasuri F.; D'Errico A.; Svegliati Baroni G.; Bolondi L.; Gramantieri L.
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
2015 Granito, Alessandro; Guidetti, Elena; Gramantieri, Laura
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma
2024 Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C.
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC
2015 Fornari, Francesca; Ferracin, Manuela; Trerè, Davide; Milazzo, Maddalena; Marinelli, Sara; Galassi, Marzia; Venerandi, Laura; Pollutri, Daniela; Patrizi, Clarissa; Borghi, Alberto; Foschi, Francesco G.; Stefanini, Giuseppe F.; Negrini, Massimo; Bolondi, Luigi; Gramantieri, Laura
Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3)
2020 Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A.
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685)
2017 Giovannini, Catia; Baglioni, Michele; Toaldo, Marco Baron; Cescon, Matteo; Bolondi, Luigi; Gramantieri, Laura
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
2007 Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension.
2004 Piscaglia F.; Donati G.; Gaiani S.; Gramantieri L.; Leoni S.; Mancini M.; Bolondi L.
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma
2020 Giovannini C.; Fornari F.; Indio V.; Trere' D.; Renzulli M.; Vasuri F.; Cescon M.; Ravaioli M.; Perrucci A.; Astolfi A.; Piscaglia F.; Gramantieri L.
Efficacy of superselective TACE in treatment of HCC
2010 Terzi E, Piscaglia F, Trimarchi C, Golfieri R, Giampalma E, Cappelli A, Renzulli M, Gramantieri L, Pini P, Serio I, Bolondi L
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions
2021 Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L
Emerging role of microRNAs in the treatment of hepatocellular carcinoma
2015 Callegari E.; Domenicali M.; Gramantieri L.; Negrini M.; Sabbioni S.
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA
2010 Minguzzi, M.; Giovannini, C.; Gramantieri, L.; Fornari, F.; Chieco, P.; Piscaglia, F.; Bolondi, L.
Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.
2004 Miotto E.; Sabbioni S.; Veronese A.; Calin G.A.; Gullini S.; Liboni A.; Gramantieri L.; Bolondi L.; Ferrazzi E.; Gafa R.; Lanza G.; Negrini M.
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation.
2005 Gramantieri L.; Chieco P.; Giovannini C.; Lacchini M.; Treré D.; Grazi G.L.; Venturi A.; Bolondi L.
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers
2021 Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area | Gramantieri L.; Gnudi F.; Vasuri F.; Mandrioli D.; Fornari F.; Tovoli F.; Suzzi F.; Vornoli A.; D...'errico A.; Piscaglia F.; Giovannini C. | 2022-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | 86. adducts.pdf; nutrients-14-01652-s001.zip |
| Animal models of hepatocellular carcinoma prevention | Shankaraiah R.C.; Gramantieri L.; Fornari F.; Sabbioni S.; Callegari E.; Negrini M. | 2019-01-01 | CANCERS | - | 1.01 Articolo in rivista | - |
| Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research | Francesca Fornari; Catia Giovannini; Fabio Piscaglia; Laura Gramantieri | 2022-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | JHC-347946-animal-models-of-hepatocellular-carcinoma--current-applicati.pdf |
| Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study | Casadei-Gardini A; Marisi G; Dadduzio V; Gramantieri L; Faloppi L; Ulivi P; Foschi F G; Tamburini... E; Vivaldi C; Rizzato M D; Ielasi L; Canale M; Conti F; Rudnas B; Fornaro L; Silvestris N; Silletta M; Cardellino G G; Lonardi S; Fornari F; Orsi G; Rovesti G; Zagonel V; Cascinu C; Scartozzi M | 2020-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | h_11585_851049 aam con copertina.pdf |
| Brivanib in combination with Notch3 silencing shows potent activity in tumour models | Giovannini C.; Salzano A.M.; Baglioni M.; Vitale M.; Scaloni A.; Zambrano N.; Giannone F.A.; Vasu...ri F.; D'Errico A.; Svegliati Baroni G.; Bolondi L.; Gramantieri L. | 2019-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | BJC.pdf; 41416.zip |
| c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma | Granito, Alessandro; Guidetti, Elena; Gramantieri, Laura | 2015-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | - |
| Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma | Gramantieri L.; Suzzi F.; Bassi C.; D'Abundo L.; Tovoli F.; Bruccoleri M.; Marseglia M.; Alimenti... E.; Fornari F.; Negrini M.; Iavarone M.; Piscaglia F.; Giovannini C. | 2024-01-01 | EUROPEAN JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | Eur J Immunol - 2023 - Gramantieri - Circulating CD8 lymphocytes predict respo.pdf; eji5648-sup-0001-suppmat.pdf |
| Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC | Fornari, Francesca; Ferracin, Manuela; Trerè, Davide; Milazzo, Maddalena; Marinelli, Sara; Galass...i, Marzia; Venerandi, Laura; Pollutri, Daniela; Patrizi, Clarissa; Borghi, Alberto; Foschi, Francesco G.; Stefanini, Giuseppe F.; Negrini, Massimo; Bolondi, Luigi; Gramantieri, Laura | 2015-01-01 | PLOS ONE | - | 1.01 Articolo in rivista | 2015_Fornari-PlosOne.pdf |
| Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3) | Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Graman...tieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A. | 2020-01-01 | TARGETED ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) | Giovannini, Catia; Baglioni, Michele; Toaldo, Marco Baron; Cescon, Matteo; Bolondi, Luigi; Graman...tieri, Laura | 2017-01-01 | SCIENTIFIC REPORTS | - | 1.04 Replica / breve intervento (e simili) | srep46920.pdf |
| Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. | Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Fer...razzi E; Grazi GL; Croce CM; Bolondi L; Negrini M | 2007-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Different haemodynamic effects of a single dose of long-acting isosorbide-5-mononitrate in healthy subjects and patients with cirrhotic portal hypertension. | Piscaglia F.; Donati G.; Gaiani S.; Gramantieri L.; Leoni S.; Mancini M.; Bolondi L. | 2004-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | - |
| Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma | Giovannini C.; Fornari F.; Indio V.; Trere' D.; Renzulli M.; Vasuri F.; Cescon M.; Ravaioli M.; P...errucci A.; Astolfi A.; Piscaglia F.; Gramantieri L. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-02674.pdf |
| Efficacy of superselective TACE in treatment of HCC | Terzi E, Piscaglia F, Trimarchi C, Golfieri R, Giampalma E, Cappelli A, Renzulli M, Gramantieri L..., Pini P, Serio I, Bolondi L | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions | Fornari, F; Giovannini, C; Piscaglia, F; Gramantieri, L | 2021-01-01 | JOURNAL OF HEPATOCELLULAR CARCINOMA | - | 1.01 Articolo in rivista | Elucidating the Molecular Basis of Sorafenib 2021.pdf |
| Emerging role of microRNAs in the treatment of hepatocellular carcinoma | Callegari E.; Domenicali M.; Gramantieri L.; Negrini M.; Sabbioni S. | 2015-01-01 | GASTROINTESTINAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA | Minguzzi, M.; Giovannini, C.; Gramantieri, L.; Fornari, F.; Chieco, P.; Piscaglia, F.; Bolondi, L. | 2010-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
| Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. | Miotto E.; Sabbioni S.; Veronese A.; Calin G.A.; Gullini S.; Liboni A.; Gramantieri L.; Bolondi L....; Ferrazzi E.; Gafa R.; Lanza G.; Negrini M. | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. | Gramantieri L.; Chieco P.; Giovannini C.; Lacchini M.; Treré D.; Grazi G.L.; Venturi A.; Bolondi L. | 2005-01-01 | HUMAN PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers | Gramantieri L.; Giovannini C.; Suzzi F.; Leoni I.; Fornari F. | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | Hepatic Cancer Stem Cells 2021.pdf |